Seven Years of Clinical Experience Outcome Review on Radium 223 Therapy In Bone Metastatic Castrate-resistant Prostate Cancer (mCRPC)

被引：0
|
作者：
Cantinho-Lopes, M. [1 ]
Pena, H. [1 ]
Filipe, P. [2 ]
Mansinho, A. [2 ]
Fernandes, I. [2 ]
Costa, L. [2 ]
机构：
[1] Fac Med Lisbon, Inst Med Nucl, Lisbon, Portugal
[2] CHULN, S Oncol, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-225
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [1] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [2] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [3] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [4] Two Years Of Clinical Experience Outcome Review On Radium223 Therapy In Bone Metastatic Castrate-resistent Prostate Cancer
    Pena, H.
    Cantinho, G.
    Graca, A.
    Fernandes, A.
    Fernandes, I.
    Costa, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S571 - S571
  • [5] Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Cox, B. W.
    Wang, L.
    Bradley, T.
    Gu, B.
    Kelley, K.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
  • [6] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [7] Single Center Clinical Experience With Radium-223 Dichloride In Patients With Metastatic Castrate-resistant Prostate Cancer
    Tiskevicius, S.
    Vidrinskaite, A.
    Stalnionis, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S572 - S572
  • [8] Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single centre experience
    Gazzilli, M.
    Durmo, R.
    Albano, D.
    Cerudelli, E.
    Panarotto, M.
    Cossalter, E.
    Bertagna, F.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S628 - S628
  • [9] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [10] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Zhang, Isabella
    Gilbo, Philip
    Kohn, Nina
    Cox, Brett
    PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457
12345